Antihypertensive medication classes and the risk of dementia over a decade of follow-up

INTRODUCTION: Use of angiotensin II (ATII)-stimulating antihypertensive medication (AHM), including angiotensin receptor blockers (ARBs) and dihydropyridine calcium channel blockers (CCBs), has been associated with lower dementia risk. Previous studies had relatively short follow-up periods. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroevers, Jakob L., Eggink, Esmé, Hoevenaar-Blom, Marieke P., Van Dalen, Jan Willem, Van Middelaar, Tessa, Van Gool, Willem A., Richard, Edo, Moll Van Charante, Eric P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799049/
https://www.ncbi.nlm.nih.gov/pubmed/36394298
http://dx.doi.org/10.1097/HJH.0000000000003324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799049/
https://www.ncbi.nlm.nih.gov/pubmed/36394298
http://dx.doi.org/10.1097/HJH.0000000000003324

Ejemplares similares